These ventures have just started at Accelerate Cambridge. They are at various stages of development, with some having already raised their first seed round.
4N Genehealth
Our vision is to develop precision medicine technologies for global healthcare challenges.
Worldwide, diabetes is affecting 425 million people. Globally, healthcare systems spend $727 billion per year to manage people with diabetes. It causes four million deaths per year. In summary, it’s an epidemic that needs to be tackled, and we want to play our part in it.
Diabetes patients have a high risk of developing long-term complications like cardiovascular diseases, retinopathy and some types of cancers. We apply emerging systems biology strategy to patients' blood samples to probe and analyse complex molecular pathways for thousands of biomarkers across genomics, biochemistry, proteomics and metabolomics to determine the personalised risk of long-term complications.
Our system provides a prognostic tool for clinicians to make effective treatment interventions saving healthcare costs and improving patient quality of life.
Blutick
Blutick is an online teaching platform that aims to be the future of education. We are starting with mathematics, and will provide automatic contextual feedback and structured support to students as they work through problems line by line, in a way that no other platform currently does.
We use machine learning to make the platform more and more intelligent, spotting common errors and giving enhanced feedback to students and teachers.
We want to teach computers how to teach, and augment the classroom experience to free up teachers from repetitive explanations and marking.
CelerX
Coeliac disease is one of the commonest autoimmune conditions affecting the developing world, with one per cent of the population believed to be affected.
Characterised by an intolerance to gluten, there are no medicinal treatments available for the condition and patients adhere to a strict gluten-free diet to ensure the avoidance of symptoms, which include nausea, stomach cramps, and diarrhoea. In spite of this, accidental gluten consumption affects 90 per cent of coeliac patients every month, and correlates to gastrointestinal aberrations in many patients.
At CelerX, we have conceptualised a prophylactic microbiome-based solution that provides constitutive protection against the problem of accidental gluten contamination. Presently, we are leveraging our technology to address unmet medical need in the coeliac disease market, however our ultimate goal is to apply our concept to a multitude of gastrointestinal conditions.
Ento AI
Ento AI provides an integrated hardware and software platform for optimising the production of insects. Trends towards 2050 predict a steady population increase to nine billion people, forcing an increased food/feed output from agriculture resulting in an even greater pressure on the environment. Scarcities of agricultural land, water, fishery and biodiversity resources, as well as nutrients and non-renewable energy are foreseen. Edible insects contain high quality protein, vitamins and amino acids for humans. Insects have a high food conversion rate, for example crickets need six times less feed than cattle, four times less than sheep, and twice less than pigs and broiler chickens to produce the same amount of protein. In addition, they emit less greenhouse gases and ammonia than conventional livestock.
Currently the large-scale production of insects is not readily practiced, this is in partly due to lack of available information on growing conditions and high labour required. Agricultural standards are not present in insect farming as is the case in intensive conventional agriculture. We are looking to develop a system to optimise output yield which constantly shields the growing environment from suboptimal conditions through combining inexpensive hardware, with state of the art computational methods. Our data platform will provide farmers a powerful cloud interface which can be used to inform business decisions whilst increasing the insect yield and also the return on investment. We aim to bring high precision agriculture to insect production through technology.
Hélix Pro
Hélix Pro is a comprehensive mental health & wellness platform, multilingual and omni-channel, converging neuroscience with human factors and deep-tech (AI and VR) to solve widespread and growing mental health issues worldwide. Lack of choice, access, inadequate support, taboos, and just quick-fix of symptoms rather than cause are some of the critical gaps. The very evident yet often overlooked matter of how closely physical health is co-related to mental health further compounds this underserved space. Our focus centred on three forms of support: (i) a multi-criteria self or assisted search for specialist counsellors, therapists or coaches; (ii) situation specific objective-led programs, (iii) self-help tools and techniques.
Mental health is a pressing matter worldwide, underserved and compounding, with over £1.2 trillion cost of social & economic impact forecast by 2025. We are solving gaps in support sought by existing and vast emerging audience, as well as solving reasons for which support, to a large extent, is not being taken up in current state, or the significant shortfalls in present solutions. As such we're solving the need for a more timely, relevant, and proactive way to address this problem area. Complexity of this space requires highly specific content and construct of support, now being developed in Cambridge for this world-wide platform.
Hélix being pioneered with the aim to 'create a more intrinsically healthy world'.
InFusion
InFusion is a company producing beverages which are derived from herbs and are completely natural, sugar-free and non-alcoholic. It is a serious drink alternative for people that cannot drink alcohol or for those who are simply conscious of their health and want to avoid chemical and sugar loaded beverages. Our customers nonetheless want to socialise with friends, to be able to immerse themselves fully into the party experience by having a cool drink in their hand. Flavour extracts such as verbena, ginger, milk thistle and lemon grass are rigorously selected and blended based on their taste and known properties. Concentrated formulas are served on the rocks, diluted in soda or mixed with other ingredients to obtain unique soft cocktails. Lighter formulas are ready to drink. InFusion brings nature into your glass and is served in bars, cafes and restaurants, enabling us to be in fusion with nature, in fusion with others, in fusion with ourselves.
LilyPop
From Roots to Plate is developing a brand new gourmet and healthy snack “LILYPOP” based on popped prickly water lily seeds. It is an ancient aquatic plant whose popped seeds are highly nutritious and naturally gluten free. The potential of this plant is underutilised and unknown outside the Indian sub-continent. Our mission is to create innovative guilt free snacking products using popped water lily seeds and in the process open up new market opportunity for the farmers and producers.
omma.tech
omma.tech intends to be the world leader in smart pest detection. Our core technology is an ultra-low-power, insect monitoring sensor that can detect infestations early. By allowing earlier, cheaper intervention we aim to put a significant dent in the global $70 billion annual cost of invasive insect pests.
Orca Scan
Orca Scan is a configurable barcode scanning app and SaaS web application that enables non-technical users to define data capture requirements in a spreadsheet format, and deliver that customisation within the Orca Scan app. Thus leveraging the power of the smartphone and the simplicity of the spreadsheet, to make barcode scanning solutions more accessible.
By utilising object recognition, the app will eventually recognise anything put in front of it, with or without a barcode, from identifying and counting beers in a crate, to surfacing the mechanical components of a vehicle part using augmented reality (AR).
